EP3003308 - NEW DRUG FOR THE TREATMENT AND/OR PREVENTION OF DEPRESSIVE DISORDERS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 06.08.2021 Database last updated on 24.08.2024 | |
Former | The patent has been granted Status updated on 28.08.2020 | ||
Former | Grant of patent is intended Status updated on 25.08.2020 | ||
Former | Examination is in progress Status updated on 05.06.2020 | ||
Former | Grant of patent is intended Status updated on 04.02.2020 | ||
Former | Examination is in progress Status updated on 07.04.2017 | Most recent event Tooltip | 27.04.2024 | Lapse of the patent in a contracting state New state(s): MK | published on 29.05.2024 [2024/22] | Applicant(s) | For all designated states Sorbonne Université 21, rue de L'École de Médecine 75006 Paris / FR | For all designated states Centre National de la Recherche Scientifique (C.N.R.S.) 3 rue Michel-Ange 75794 Paris Cedex 16 / FR | For all designated states Assistance Publique Hôpitaux de Paris 3, Avenue Victoria 75184 Paris Cedex 04 / FR | For all designated states Université Paris Descartes 12, Rue de l'Ecole de Médecine 75006 Paris 6 / FR | [2020/40] |
Former [2018/29] | For all designated states Sorbonne Universite 21 rue de L'École de Médecine 75006 Paris / FR | ||
For all designated states Centre National de la Recherche Scientifique (C.N.R.S.) 3 rue Michel-Ange 75794 Paris Cedex 16 / FR | |||
For all designated states Assistance Publique Hôpitaux de Paris 3, Avenue Victoria 75184 Paris Cedex 04 / FR | |||
For all designated states Université Paris Descartes 12, Rue de l'Ecole de Médecine 75006 Paris 6 / FR | |||
Former [2016/15] | For all designated states Université Pierre et Marie Curie (Paris 6) 4, Place Jussieu 75005 Paris / FR | ||
For all designated states Centre National de la Recherche Scientifique (CNRS) 3, rue Michel-Ange 75794 Paris Cedex 16 / FR | |||
For all designated states Assistance Publique Hôpitaux de Paris 3, Avenue Victoria 75184 Paris Cedex 04 / FR | |||
For all designated states Université Paris Descartes 12, Rue de l'Ecole de Médecine 75006 Paris 6 / FR | Inventor(s) | 01 /
BENOLIEL, Jean-Jacques 54 rue de Picpus F-75012 Paris / FR | 02 /
BECKER, Christel 25 rue du Borrégo F-75020 Paris / FR | 03 /
BOUVIER, Elodie 28 allée Louis Breguet 94310 Orly / FR | [2016/15] | Representative(s) | Grosset-Fournier, Chantal Catherine, et al Grosset-Fournier & Demachy 54, rue Saint-Lazare 75009 Paris / FR | [2016/15] | Application number, filing date | 14728158.8 | 30.05.2014 | [2016/15] | WO2014EP61240 | Priority number, date | EP20130169936 | 30.05.2013 Original published format: EP 13169936 | [2016/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014191547 | Date: | 04.12.2014 | Language: | EN | [2014/49] | Type: | A1 Application with search report | No.: | EP3003308 | Date: | 13.04.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.12.2014 takes the place of the publication of the European patent application. | [2016/15] | Type: | B1 Patent specification | No.: | EP3003308 | Date: | 30.09.2020 | Language: | EN | [2020/40] | Search report(s) | International search report - published on: | EP | 04.12.2014 | Classification | IPC: | A61K31/445, A61P25/24 | [2016/15] | CPC: |
A61K31/445 (EP,US);
A61K31/135 (EP,US);
A61K31/138 (EP,US);
A61K31/15 (EP,US);
A61K31/343 (EP,US);
A61K31/381 (EP,US);
A61K31/5375 (EP,US);
A61K31/55 (EP,US);
A61K33/00 (EP,US);
| C-Set: |
A61K31/135, A61K2300/00 (EP,US);
A61K31/138, A61K2300/00 (US,EP);
A61K31/15, A61K2300/00 (US,EP);
A61K31/343, A61K2300/00 (US,EP);
A61K31/381, A61K2300/00 (EP,US);
A61K31/445, A61K2300/00 (US,EP);
A61K31/5375, A61K2300/00 (EP,US);
A61K31/55, A61K2300/00 (EP,US); | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/15] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | NEUES ARZNEIMITTEL ZUR BEHANDLUNG UND/ODER VORBEUGUNG VON DEPRESSIONSERKRANKUNGEN | [2016/15] | English: | NEW DRUG FOR THE TREATMENT AND/OR PREVENTION OF DEPRESSIVE DISORDERS | [2016/15] | French: | NOUVEAU MÉDICAMENT POUR LE TRAITEMENT ET/OU LA PRÉVENTION DES TROUBLES DÉPRESSIFS | [2019/47] |
Former [2016/15] | NOUVEAU MÉDICAMENT POUR LE TRAITEMENT ET/OU LA PRÉVENTION DE TROUBLES DÉPRESSIFS | Entry into regional phase | 02.11.2015 | National basic fee paid | 02.11.2015 | Designation fee(s) paid | 02.11.2015 | Examination fee paid | Examination procedure | 02.11.2015 | Examination requested [2016/15] | 05.07.2016 | Amendment by applicant (claims and/or description) | 06.04.2017 | Despatch of a communication from the examining division (Time limit: M07) | 13.11.2017 | Reply to a communication from the examining division | 30.10.2018 | Despatch of a communication from the examining division (Time limit: M04) | 26.02.2019 | Reply to a communication from the examining division | 05.02.2020 | Communication of intention to grant the patent | 02.06.2020 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 02.06.2020 | Receipt of the translation of the claim(s) | 05.06.2020 | Fee for grant paid | 05.06.2020 | Fee for publishing/printing paid | 25.08.2020 | Information about intention to grant a patent | 25.08.2020 | Receipt of the translation of the claim(s) | Opposition(s) | 01.07.2021 | No opposition filed within time limit [2021/36] | Fees paid | Renewal fee | 31.05.2016 | Renewal fee patent year 03 | 31.05.2017 | Renewal fee patent year 04 | 31.05.2018 | Renewal fee patent year 05 | 31.05.2019 | Renewal fee patent year 06 | 29.05.2020 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 30.05.2014 | AL | 30.09.2020 | AT | 30.09.2020 | CY | 30.09.2020 | CZ | 30.09.2020 | DK | 30.09.2020 | EE | 30.09.2020 | ES | 30.09.2020 | FI | 30.09.2020 | HR | 30.09.2020 | IT | 30.09.2020 | LT | 30.09.2020 | LV | 30.09.2020 | MC | 30.09.2020 | MK | 30.09.2020 | NL | 30.09.2020 | PL | 30.09.2020 | RO | 30.09.2020 | RS | 30.09.2020 | SE | 30.09.2020 | SI | 30.09.2020 | SK | 30.09.2020 | SM | 30.09.2020 | BG | 30.12.2020 | NO | 30.12.2020 | GR | 31.12.2020 | IS | 30.01.2021 | PT | 01.02.2021 | GB | 30.05.2021 | IE | 30.05.2021 | LU | 30.05.2021 | BE | 31.05.2021 | CH | 31.05.2021 | FR | 31.05.2021 | LI | 31.05.2021 | [2024/22] |
Former [2023/30] | HU | 30.05.2014 | |
AL | 30.09.2020 | ||
AT | 30.09.2020 | ||
CY | 30.09.2020 | ||
CZ | 30.09.2020 | ||
DK | 30.09.2020 | ||
EE | 30.09.2020 | ||
ES | 30.09.2020 | ||
FI | 30.09.2020 | ||
HR | 30.09.2020 | ||
IT | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
MC | 30.09.2020 | ||
NL | 30.09.2020 | ||
PL | 30.09.2020 | ||
RO | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
SI | 30.09.2020 | ||
SK | 30.09.2020 | ||
SM | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
IS | 30.01.2021 | ||
PT | 01.02.2021 | ||
GB | 30.05.2021 | ||
IE | 30.05.2021 | ||
LU | 30.05.2021 | ||
BE | 31.05.2021 | ||
CH | 31.05.2021 | ||
FR | 31.05.2021 | ||
LI | 31.05.2021 | ||
Former [2023/29] | HU | 30.05.2014 | |
AL | 30.09.2020 | ||
AT | 30.09.2020 | ||
CZ | 30.09.2020 | ||
DK | 30.09.2020 | ||
EE | 30.09.2020 | ||
ES | 30.09.2020 | ||
FI | 30.09.2020 | ||
HR | 30.09.2020 | ||
IT | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
MC | 30.09.2020 | ||
NL | 30.09.2020 | ||
PL | 30.09.2020 | ||
RO | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
SI | 30.09.2020 | ||
SK | 30.09.2020 | ||
SM | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
IS | 30.01.2021 | ||
PT | 01.02.2021 | ||
GB | 30.05.2021 | ||
IE | 30.05.2021 | ||
LU | 30.05.2021 | ||
BE | 31.05.2021 | ||
CH | 31.05.2021 | ||
FR | 31.05.2021 | ||
LI | 31.05.2021 | ||
Former [2022/34] | AL | 30.09.2020 | |
AT | 30.09.2020 | ||
CZ | 30.09.2020 | ||
DK | 30.09.2020 | ||
EE | 30.09.2020 | ||
ES | 30.09.2020 | ||
FI | 30.09.2020 | ||
HR | 30.09.2020 | ||
IT | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
MC | 30.09.2020 | ||
NL | 30.09.2020 | ||
PL | 30.09.2020 | ||
RO | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
SI | 30.09.2020 | ||
SK | 30.09.2020 | ||
SM | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
IS | 30.01.2021 | ||
PT | 01.02.2021 | ||
GB | 30.05.2021 | ||
IE | 30.05.2021 | ||
LU | 30.05.2021 | ||
BE | 31.05.2021 | ||
CH | 31.05.2021 | ||
FR | 31.05.2021 | ||
LI | 31.05.2021 | ||
Former [2022/23] | AL | 30.09.2020 | |
AT | 30.09.2020 | ||
CZ | 30.09.2020 | ||
DK | 30.09.2020 | ||
EE | 30.09.2020 | ||
ES | 30.09.2020 | ||
FI | 30.09.2020 | ||
HR | 30.09.2020 | ||
IT | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
MC | 30.09.2020 | ||
NL | 30.09.2020 | ||
PL | 30.09.2020 | ||
RO | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
SI | 30.09.2020 | ||
SK | 30.09.2020 | ||
SM | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
IS | 30.01.2021 | ||
PT | 01.02.2021 | ||
GB | 30.05.2021 | ||
IE | 30.05.2021 | ||
LU | 30.05.2021 | ||
CH | 31.05.2021 | ||
FR | 31.05.2021 | ||
LI | 31.05.2021 | ||
Former [2022/22] | AL | 30.09.2020 | |
AT | 30.09.2020 | ||
CZ | 30.09.2020 | ||
DK | 30.09.2020 | ||
EE | 30.09.2020 | ||
ES | 30.09.2020 | ||
FI | 30.09.2020 | ||
HR | 30.09.2020 | ||
IT | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
MC | 30.09.2020 | ||
NL | 30.09.2020 | ||
PL | 30.09.2020 | ||
RO | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
SI | 30.09.2020 | ||
SK | 30.09.2020 | ||
SM | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
PT | 01.02.2021 | ||
GB | 30.05.2021 | ||
IE | 30.05.2021 | ||
LU | 30.05.2021 | ||
CH | 31.05.2021 | ||
LI | 31.05.2021 | ||
Former [2022/21] | AL | 30.09.2020 | |
AT | 30.09.2020 | ||
CZ | 30.09.2020 | ||
DK | 30.09.2020 | ||
EE | 30.09.2020 | ||
ES | 30.09.2020 | ||
FI | 30.09.2020 | ||
HR | 30.09.2020 | ||
IT | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
MC | 30.09.2020 | ||
NL | 30.09.2020 | ||
PL | 30.09.2020 | ||
RO | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
SI | 30.09.2020 | ||
SK | 30.09.2020 | ||
SM | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
PT | 01.02.2021 | ||
IE | 30.05.2021 | ||
LU | 30.05.2021 | ||
CH | 31.05.2021 | ||
LI | 31.05.2021 | ||
Former [2022/10] | AL | 30.09.2020 | |
AT | 30.09.2020 | ||
CZ | 30.09.2020 | ||
DK | 30.09.2020 | ||
EE | 30.09.2020 | ||
ES | 30.09.2020 | ||
FI | 30.09.2020 | ||
HR | 30.09.2020 | ||
IT | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
MC | 30.09.2020 | ||
NL | 30.09.2020 | ||
PL | 30.09.2020 | ||
RO | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
SI | 30.09.2020 | ||
SK | 30.09.2020 | ||
SM | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
PT | 01.02.2021 | ||
LU | 30.05.2021 | ||
CH | 31.05.2021 | ||
LI | 31.05.2021 | ||
Former [2022/09] | AL | 30.09.2020 | |
AT | 30.09.2020 | ||
CZ | 30.09.2020 | ||
DK | 30.09.2020 | ||
EE | 30.09.2020 | ||
ES | 30.09.2020 | ||
FI | 30.09.2020 | ||
HR | 30.09.2020 | ||
IT | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
MC | 30.09.2020 | ||
NL | 30.09.2020 | ||
PL | 30.09.2020 | ||
RO | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
SI | 30.09.2020 | ||
SK | 30.09.2020 | ||
SM | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
IS | 30.01.2021 | ||
PT | 01.02.2021 | ||
LU | 30.05.2021 | ||
Former [2022/07] | AL | 30.09.2020 | |
AT | 30.09.2020 | ||
CZ | 30.09.2020 | ||
DK | 30.09.2020 | ||
EE | 30.09.2020 | ||
ES | 30.09.2020 | ||
FI | 30.09.2020 | ||
HR | 30.09.2020 | ||
IT | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
MC | 30.09.2020 | ||
NL | 30.09.2020 | ||
PL | 30.09.2020 | ||
RO | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
SI | 30.09.2020 | ||
SK | 30.09.2020 | ||
SM | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
IS | 30.01.2021 | ||
PT | 01.02.2021 | ||
Former [2021/50] | AL | 30.09.2020 | |
AT | 30.09.2020 | ||
CZ | 30.09.2020 | ||
DK | 30.09.2020 | ||
EE | 30.09.2020 | ||
ES | 30.09.2020 | ||
FI | 30.09.2020 | ||
HR | 30.09.2020 | ||
IT | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
NL | 30.09.2020 | ||
PL | 30.09.2020 | ||
RO | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
SI | 30.09.2020 | ||
SK | 30.09.2020 | ||
SM | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
IS | 30.01.2021 | ||
PT | 01.02.2021 | ||
Former [2021/48] | AL | 30.09.2020 | |
AT | 30.09.2020 | ||
CZ | 30.09.2020 | ||
DK | 30.09.2020 | ||
EE | 30.09.2020 | ||
ES | 30.09.2020 | ||
FI | 30.09.2020 | ||
HR | 30.09.2020 | ||
IT | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
NL | 30.09.2020 | ||
PL | 30.09.2020 | ||
RO | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
SK | 30.09.2020 | ||
SM | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
IS | 30.01.2021 | ||
PT | 01.02.2021 | ||
Former [2021/37] | AL | 30.09.2020 | |
AT | 30.09.2020 | ||
CZ | 30.09.2020 | ||
DK | 30.09.2020 | ||
EE | 30.09.2020 | ||
ES | 30.09.2020 | ||
FI | 30.09.2020 | ||
HR | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
NL | 30.09.2020 | ||
PL | 30.09.2020 | ||
RO | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
SK | 30.09.2020 | ||
SM | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
IS | 30.01.2021 | ||
PT | 01.02.2021 | ||
Former [2021/28] | AL | 30.09.2020 | |
AT | 30.09.2020 | ||
CZ | 30.09.2020 | ||
EE | 30.09.2020 | ||
ES | 30.09.2020 | ||
FI | 30.09.2020 | ||
HR | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
NL | 30.09.2020 | ||
PL | 30.09.2020 | ||
RO | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
SK | 30.09.2020 | ||
SM | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
IS | 30.01.2021 | ||
PT | 01.02.2021 | ||
Former [2021/25] | AL | 30.09.2020 | |
AT | 30.09.2020 | ||
CZ | 30.09.2020 | ||
EE | 30.09.2020 | ||
ES | 30.09.2020 | ||
FI | 30.09.2020 | ||
HR | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
NL | 30.09.2020 | ||
PL | 30.09.2020 | ||
RO | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
SM | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
IS | 30.01.2021 | ||
PT | 01.02.2021 | ||
Former [2021/24] | AT | 30.09.2020 | |
CZ | 30.09.2020 | ||
EE | 30.09.2020 | ||
FI | 30.09.2020 | ||
HR | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
NL | 30.09.2020 | ||
RO | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
SM | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
PT | 01.02.2021 | ||
Former [2021/23] | CZ | 30.09.2020 | |
EE | 30.09.2020 | ||
FI | 30.09.2020 | ||
HR | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
NL | 30.09.2020 | ||
RO | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
SM | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
PT | 01.02.2021 | ||
Former [2021/22] | CZ | 30.09.2020 | |
EE | 30.09.2020 | ||
FI | 30.09.2020 | ||
HR | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
NL | 30.09.2020 | ||
RO | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
PT | 01.02.2021 | ||
Former [2021/21] | FI | 30.09.2020 | |
HR | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
NL | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
PT | 01.02.2021 | ||
Former [2021/20] | FI | 30.09.2020 | |
HR | 30.09.2020 | ||
LT | 30.09.2020 | ||
LV | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
Former [2021/10] | FI | 30.09.2020 | |
HR | 30.09.2020 | ||
LV | 30.09.2020 | ||
RS | 30.09.2020 | ||
SE | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
GR | 31.12.2020 | ||
Former [2021/08] | FI | 30.09.2020 | |
SE | 30.09.2020 | ||
BG | 30.12.2020 | ||
NO | 30.12.2020 | ||
Former [2021/07] | FI | 30.09.2020 | |
NO | 30.12.2020 | Cited in | International search | [XI]WO2004111021 (BTG INT LTD [GB], et al) [X] 1 * examples 6,7,8,12,13 * [I] 2-15; | [AD]US2012115905 (PROCTOR PETER HERBER [US]) [AD] 1-15 * paragraph [0115] *; | [XI] - FEDOCE A ET AL, "Systemic administration of tempol, an antioxidant agent, attenuates the increased conditioned emotional response induced by restraint-stress", SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER, & 42ND ANNUAL MEETING OF THE SOCIETY-FOR-NEUROSCIENCE; NEW ORLEANS, LA, USA; OCTOBER 13 -17, 2012, (2012), vol. 42, XP009170718 [X] 1,4-10 * the whole document * [I] 2,3,11-15 | [I] - ROBERT D. ROGHAIR ET AL, "Maternal antioxidant blocks programmed cardiovascular and behavioural stress responses in adult mice", CLINICAL SCIENCE, (20110725), vol. 7, no. 10, doi:10.1371/journal.pone.0009250, ISSN 0143-5221, pages 265 - 436, XP055126039 [I] 1-15 * figure 1 * DOI: http://dx.doi.org/10.1042/CS20110153 | Examination | WO0130352 | WO2009147681 | - A Teichner ET AL, "Combination of dexanabinol and tempol in focal cerebral ischemia: is there a ceiling effect?", Experimental Neurology, AMSTERDAM, NL, (20030801), vol. 182, no. 2, doi:10.1016/S0014-4886(03)00083-9, ISSN 0014-4886, pages 353 - 360, XP055471646 DOI: http://dx.doi.org/10.1016/S0014-4886(03)00083-9 |